Victrex Förvaltning
Förvaltning kriterier kontrolleras 2/4
Victrex VD är James Routh, utsedd i Jan 2026, har en anställningstid på mindre än ett år. äger direkt 0.042% av företagets aktier, värda £ 223.71K. Den genomsnittliga mandatperioden för ledningsgruppen och styrelsen är 3.8 år respektive 4.1 år.
Viktig information
James Routh
Verkställande direktör
n/a
Total ersättning
| VD-lön i procent | n/a |
| Anställning som VD | less than a year |
| Ägande av VD | 0.04% |
| Ledningens genomsnittliga anställningstid | 3.8yrs |
| Styrelsens genomsnittliga mandatperiod | 4.1yrs |
Senaste uppdateringar av ledningen
Recent updates
Uppdatering av berättelse • May 21
VCT: Margin Execution And Lower P/E Framework Will Support Future Re Rating
Analysts have trimmed their implied price target on Victrex by about £0.39, citing updated assumptions around profit margins, revenue growth and a lower future P/E multiple following recent Street research. Analyst Commentary Street research around Victrex has shifted to a more cautious stance on valuation, with the latest move being a £1.00 cut to the implied price target from JPMorgan.
Uppdatering av berättelse • May 01
VCT: Cautious P E And Discount Rate Assumptions Will Shape Future Rerating
Analysts have trimmed their price target on Victrex by £1.00, citing updated assumptions around the discount rate, revenue growth, profit margins and future P/E. These changes modestly adjust their outlook on the shares.Uppdatering av berättelse • Apr 17
VCT: Cautious Growth And Margin Assumptions Will Shape Future P E Rerating
Analysts have lowered their price target on Victrex by £1.00, citing updates to assumptions around discount rate, revenue growth, profit margin and future P/E that collectively suggest a more balanced risk and return profile. Analyst Commentary Recent commentary around Victrex has tilted more cautious, with the latest £1.00 cut in the price target, including the 100 GBp adjustment referenced in recent research, highlighting increased focus on valuation and execution risks.Uppdatering av berättelse • Apr 03
VCT: Refined Cash Flow Assumptions Will Support Future Re Rating Potential
Analysts have trimmed their price target on Victrex by £1.00, citing updated assumptions around discount rates, revenue growth, and profit margins as key drivers of the revision. Analyst Commentary JPMorgan has reduced its price target on Victrex by £1.00, reflecting refreshed assumptions around discount rates, revenue growth, and margins.
Uppdatering av berättelse • Mar 19
VCT: Future Upside Will Be Anchored By Resilient Earnings Framework
Analysts have trimmed their price target on Victrex by £1.00, reflecting slightly lower fair value estimates and modestly softer assumptions for revenue growth and profit margins, while still using a similar discount rate and future P/E multiple. Analyst Commentary Bullish Takeaways Bullish analysts view the £1.00 reduction in the price target as a fine tuning of fair value rather than a shift in the long term thesis, with the core assumptions on discount rate and future P/E multiple kept broadly intact.Uppdatering av berättelse • Mar 05
VCT: Future Upside Will Be Supported By Resilient Earnings Assumptions
Analysts have trimmed their price target for Victrex to £7.32 from £7.48. This reflects updated views on its long term fair value, discount rate, revenue growth, profit margin and future P/E assumptions.Uppdatering av berättelse • Feb 19
VCT: Higher Growth Assumptions Will Set Up Future Re Rating Opportunity
Analysts have trimmed their price target for Victrex to £8.90. This reflects slightly higher assumed discount and revenue growth rates, together with a small adjustment to forecast profit margins and future P/E expectations.Uppdatering av berättelse • Feb 05
VCT: Sector Downgrade And Lower Future P E Multiple Will Cap Rerating Potential
Analysts have trimmed their price expectations for Victrex, reflecting slightly higher discount rate assumptions, modestly different revenue growth and profit margin forecasts, and a lower future P/E multiple in light of more cautious sector views on European chemicals. Analyst Commentary Bearish analysts have taken a more cautious stance on Victrex, in line with a broader push to reduce risk within European chemicals.Analysartikel • Jan 27
Does Victrex (LON:VCT) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Uppdatering av berättelse • Jan 22
VCT: Sector Downgrade Will Set Up Opportunity For Future Re‑Rating
Analysts have reduced their fair value estimate for Victrex from £11.00 to £8.90, citing more cautious views on diversified chemicals and a preference for other parts of the European chemicals sector as key drivers of the updated price target assumptions. Analyst Commentary Recent research highlights a more cautious stance on diversified chemicals, with Victrex now grouped alongside peers where sentiment is restrained compared with preferred sub sectors such as industrial gases, ingredients, and distributors.Analysartikel • Jan 09
Victrex (LON:VCT) Has Affirmed Its Dividend Of £0.4614
The board of Victrex plc ( LON:VCT ) has announced that it will pay a dividend of £0.4614 per share on the 27th of...Uppdatering av berättelse • Jan 08
VCT: Future Upside Will Be Driven By Resilient Earnings Power
Narrative Update Analysts have trimmed their fair value estimate for Victrex to reflect a lower price target of £9.40 from £11.00, citing a more cautious stance on European chemicals while still noting relatively steady assumptions for growth, margins and future P/E. Analyst Commentary Recent research updates on Victrex point to a more mixed stance, with some analysts maintaining a constructive view on the shares and others taking a more cautious approach to the broader European chemicals space.Uppdatering av berättelse • Dec 24
VCT: Sector Caution And Rating Downgrade Will Pressure Share Rerating Potential
Analysts have trimmed their fair value estimate for Victrex from £6.75 to £5.75, reflecting a slightly higher discount rate, softer medium term revenue and margin expectations, and recent price target cuts from the Street. Analyst Commentary Recent Street updates underline a more cautious stance on Victrex, with bearish analysts revising ratings and price targets lower in response to sector headwinds and company specific execution risks.Analysartikel • Dec 24
Victrex (LON:VCT) Is Due To Pay A Dividend Of £0.4614
The board of Victrex plc ( LON:VCT ) has announced that it will pay a dividend on the 27th of February, with investors...Uppdatering av berättelse • Dec 10
VCT: Future Upside Will Be Driven By Medical Volume Rebound
Analysts have trimmed their price targets on Victrex, cutting the implied fair value by roughly 2 percent to reflect softer margin expectations and sector headwinds, even as they acknowledge improving revenue growth prospects along with a higher future P/E multiple. Analyst Commentary Street commentary on Victrex has become more balanced, with recent notes highlighting both improving medium term growth prospects and persistent execution risks that could cap near term upside.Analysartikel • Dec 10
We Like The Quality Of Victrex's (LON:VCT) Earnings
Shareholders appeared to be happy with Victrex plc's ( LON:VCT ) solid earnings report last week. This reaction by the...Analysartikel • Dec 05
Victrex (LON:VCT) Has Announced A Dividend Of £0.4614
Victrex plc ( LON:VCT ) will pay a dividend of £0.4614 on the 27th of February. Based on this payment, the dividend...Uppdatering av berättelse • Nov 26
VCT: Future Recovery Will Be Driven By Medical Volume Rebound
Victrex's analyst price targets have been revised downward, with a notable reduction from previous estimates such as 1,100 GBp to 940 GBp. Analysts cite ongoing caution towards the European chemicals sector and softer expectations for the company's recovery. Analyst Commentary Recent analyst assessments reflect a shift in sentiment towards Victrex's near-term performance and sector positioning.Uppdatering av berättelse • Nov 11
VCT: Future Leadership Transition Will Guide Recovery As Margins Improve
Analysts have reduced their price targets for Victrex, with consensus moving from approximately £8.77 to £8.11 per share. This reflects concerns about weaker profit margins and slower growth forecasts in the chemicals sector.Analysartikel • Oct 11
Market Participants Recognise Victrex plc's (LON:VCT) Earnings
When close to half the companies in the United Kingdom have price-to-earnings ratios (or "P/E's") below 16x, you may...Analysartikel • Jun 28
Capital Allocation Trends At Victrex (LON:VCT) Aren't Ideal
When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...Analysartikel • May 19
We Think Victrex's (LON:VCT) Healthy Earnings Might Be Conservative
The market seemed underwhelmed by the solid earnings posted by Victrex plc ( LON:VCT ) recently. We have done some...Analysartikel • May 15
Victrex's (LON:VCT) Dividend Will Be £0.1342
Victrex plc's ( LON:VCT ) investors are due to receive a payment of £0.1342 per share on 27th of June. This makes the...Ny berättelse • May 12
China Plant And Magma Programme Will Expand Market Reach
Initiatives like Project Vista and the new China plant aim to improve sales strategies and expand geographically, enhancing margins and growth potential.Analysartikel • Apr 08
With A 31% Price Drop For Victrex plc (LON:VCT) You'll Still Get What You Pay For
Victrex plc ( LON:VCT ) shareholders that were waiting for something to happen have been dealt a blow with a 31% share...Analysartikel • Mar 24
Victrex (LON:VCT) Is Finding It Tricky To Allocate Its Capital
When researching a stock for investment, what can tell us that the company is in decline? When we see a declining...Analysartikel • Feb 26
Are Investors Undervaluing Victrex plc (LON:VCT) By 49%?
Key Insights Victrex's estimated fair value is UK£18.18 based on 2 Stage Free Cash Flow to Equity Victrex's UK£9.32...Analysartikel • Jan 15
Victrex (LON:VCT) Is Paying Out A Dividend Of £0.4614
Victrex plc ( LON:VCT ) will pay a dividend of £0.4614 on the 21st of February. Based on this payment, the dividend...Analysartikel • Dec 06
Victrex plc (LON:VCT) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable
Victrex plc ( LON:VCT ) shareholders would be excited to see that the share price has had a great month, posting a 25...Analysartikel • Sep 13
Investors Could Be Concerned With Victrex's (LON:VCT) Returns On Capital
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analysartikel • Aug 03
Shareholders Should Be Pleased With Victrex plc's (LON:VCT) Price
With a price-to-earnings (or "P/E") ratio of 29.8x Victrex plc ( LON:VCT ) may be sending very bearish signals at the...Analysartikel • Jul 16
Does Victrex (LON:VCT) Have A Healthy Balance Sheet?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Analysartikel • Jun 14
There Are Reasons To Feel Uneasy About Victrex's (LON:VCT) Returns On Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Analysartikel • May 27
Calculating The Fair Value Of Victrex plc (LON:VCT)
Key Insights Victrex's estimated fair value is UK£14.70 based on 2 Stage Free Cash Flow to Equity With UK£12.96 share...Analysartikel • Mar 16
Does Victrex (LON:VCT) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analysartikel • Feb 24
Returns On Capital At Victrex (LON:VCT) Paint A Concerning Picture
When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...Analysartikel • Jan 12
Victrex plc Just Missed EPS By 5.9%: Here's What Analysts Think Will Happen Next
Shareholders might have noticed that Victrex plc ( LON:VCT ) filed its annual result this time last week. The early...Analysartikel • Dec 08
Victrex (LON:VCT) Will Pay A Dividend Of £0.4614
Victrex plc's ( LON:VCT ) investors are due to receive a payment of £0.4614 per share on 23rd of February. This means...Analysartikel • Nov 23
Investors Could Be Concerned With Victrex's (LON:VCT) Returns On Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...Analysartikel • Oct 19
Is Victrex plc (LON:VCT) Trading At A 22% Discount?
Key Insights Victrex's estimated fair value is UK£17.25 based on 2 Stage Free Cash Flow to Equity Victrex's UK£13.47...Analysartikel • Sep 04
Is Victrex plc (LON:VCT) Potentially Undervalued?
Victrex plc ( LON:VCT ), might not be a large cap stock, but it saw a decent share price growth in the teens level on...Analysartikel • Aug 17
Victrex (LON:VCT) Could Be Struggling To Allocate Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...Analysartikel • Jul 22
These 4 Measures Indicate That Victrex (LON:VCT) Is Using Debt Reasonably Well
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analysartikel • Jun 30
Calculating The Fair Value Of Victrex plc (LON:VCT)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Victrex fair value estimate is UK£15.40 With UK£13.66 share...Analysartikel • Jun 15
Need To Know: The Consensus Just Cut Its Victrex plc (LON:VCT) Estimates For 2023
Market forces rained on the parade of Victrex plc ( LON:VCT ) shareholders today, when the analysts downgraded their...VD OCH KONCERNCHEF
James Routh (52 yo)
less than a year
Anställning
Dr. James Mathew Routh, Ph D., is Chief Executive Officer & Executive Director of Victrex plc from January 1, 2026. Dr. Routh serves as Senior Independent Non-Executive Director of Tracsis plc since Septem...
Ledningsgrupp
| Namn | Position | Anställning | Kompensation | Ägarskap |
|---|---|---|---|---|
| CFO & Executive Director | 3.8yrs | UK£635.21k | 0.015% £ 82.4k | |
| CEO & Executive Director | less than a year | inga uppgifter | 0.042% £ 223.7k | |
| Director of Investor Relations | 12.9yrs | inga uppgifter | inga uppgifter | |
| General Counsel & Company Secretary | 4.8yrs | inga uppgifter | inga uppgifter | |
| Group Human Resource Director | no data | inga uppgifter | inga uppgifter | |
| Managing Director for Medical | 2.7yrs | inga uppgifter | inga uppgifter | |
| Managing Director of Sustainable Solutions | no data | inga uppgifter | inga uppgifter |
3.8yrs
Genomsnittlig anställningstid
Erfaren ledning: VCT s ledningsgrupp anses vara erfaren ( 3.8 års genomsnittlig anställningstid).
Styrelseledamöter
| Namn | Position | Anställning | Kompensation | Ägarskap |
|---|---|---|---|---|
| CFO & Executive Director | 3.8yrs | UK£635.21k | 0.015% £ 82.4k | |
| CEO & Executive Director | less than a year | inga uppgifter | 0.042% £ 223.7k | |
| Independent Non-Executive Chair | 4.4yrs | UK£280.00k | 0.0080% £ 42.9k | |
| Non-Executive Director | less than a year | inga uppgifter | inga uppgifter | |
| Independent Non-Executive Director | 8.3yrs | UK£68.00k | 0.0021% £ 11.3k | |
| Independent Non-Executive Director | 8.3yrs | UK£70.50k | 0.0036% £ 19.4k | |
| Senior Independent Director | 6yrs | UK£69.40k | 0.0022% £ 12.0k | |
| Independent Non-Executive Director | 2yrs | UK£58.50k | 0.00011% £ 591.0 |
4.1yrs
Genomsnittlig anställningstid
65.5yo
Genomsnittlig ålder
Erfaren styrelse: VCT s styrelse anses vara erfaren ( 4.1 års genomsnittlig mandatperiod).
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/05/22 20:16 |
| Aktiekurs vid dagens slut | 2026/05/22 00:00 |
| Intäkter | 2026/03/31 |
| Årlig intjäning | 2025/09/30 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Victrex plc bevakas av 31 analytiker. 12 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Gunther Zechmann | Barclays |
| Katie Richards | Barclays |
| James Stewart | Barclays |